All Episodes

February 18, 2024 53 mins

Welcome to the Blue Beryl, a podcast with intelligent conversations about Buddhism, Asian Medicine, and embodied spirituality.  In this episode, host Dr Pierce Salguero sits down with BBP producer Dr Lan Li to reflect on Season 1 and look ahead to Season 2. We discuss showing up for scholarly work as a whole person, how studying Buddhist medicine challenges the academic status quo, and what do I mean by calling Season 2 “embodied spirituality”? Along the way, we touch on talismanic chants, poisonous centipedes,  dissolving bodies, and the unfolding mystery that this podcast is pursuing.

Enjoy! And subscribe to Blue Beryl for monthly episodes.

Resources mentioned in this episode:

Mark as Played

Advertise With Us

Popular Podcasts

Stuff You Should Know
Dateline NBC

Dateline NBC

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com

The Male Room with Dr. Jesse Mills

The Male Room with Dr. Jesse Mills

As Director of The Men’s Clinic at UCLA, Dr. Jesse Mills has spent his career helping men understand their bodies, their hormones, and their health. Now he’s bringing that expertise to The Male Room — a podcast where data-driven medicine meets common sense. Each episode separates fact from hype, science from snake oil, and gives men the tools to live longer, stronger, and happier lives. With candor, humor, and real-world experience from the exam room and the operating room, Dr. Mills breaks down the latest health headlines, dissects trends, and explains what actually works — and what doesn’t. Smart, straightforward, and entertaining, The Male Room is the show that helps men take charge of their health without the jargon.

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2025 iHeartMedia, Inc.